Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of GnRH agonist vs. antagonist.

被引：1
|
作者：
Boostanfar, R [1 ]
Slater, C [1 ]
Klumph, S [1 ]
Saadat, P [1 ]
Tourgeman, D [1 ]
Paulson, RJ [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Dept OB GYN, Div Reprod Endocrinol & Infertil, Los Angeles, CA USA
来源：
FERTILITY AND STERILITY | 2002年 / 77卷 / 04期
关键词：
D O I：
10.1016/S0015-0282(02)03022-4
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O12
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [41] Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
    Devjak, Rok
    Tacer, Klementina Fon
    Juvan, Peter
    Klun, Irma Virant
    Rozman, Damjana
    Bokal, Eda Vrtacnik
    [J]. PLOS ONE, 2012, 7 (10):
  • [42] Intraindividual Embryo Morphokinetics Are Not Affected by a Switch of the Ovarian Stimulation Protocol Between GnRH Agonist vs. Antagonist Regimens in Consecutive Cycles
    Dietrich, Jens E.
    Freis, Alexander
    Beedgen, Franziska
    von Horn, Kyra
    Holschbach, Verena
    Liebscher, Julia
    Strowitzki, Thomas
    Germeyer, Ariane
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [43] Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation and use of a gonadotrophin releasing hormone antagonist
    Vani, S.
    Macdonald, S.
    Williams, A. R. W.
    Mason, J. I.
    Thong, K. J.
    Critchley, H. O. D.
    [J]. HUMAN REPRODUCTION, 2007, 22 : I44 - I45
  • [44] GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2021, 86 (05) : 427 - 431
  • [45] Comparison of GnRH agonist and antagonist protocols for controlled ovarian hyperstimulation (COH) in poor response IVF patients.
    Winston, NJ
    Puccini, M
    Nelson, L
    Scoccia, H
    [J]. FERTILITY AND STERILITY, 2004, 82 : S123 - S124
  • [46] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Ginevra Mills
    Michael H. Dahan
    [J]. Archives of Gynecology and Obstetrics, 2022, 306 : 1731 - 1737
  • [47] Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
    Toftager, M.
    Bogstad, J.
    Bryndorf, T.
    Lossl, K.
    Roskaer, J.
    Holland, T.
    Praetorius, L.
    Zedeler, A.
    Nilas, L.
    Pinborg, A.
    [J]. HUMAN REPRODUCTION, 2016, 31 (06) : 1253 - 1264
  • [48] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Mills, Ginevra
    Dahan, Michael H.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (05) : 1731 - 1737
  • [49] GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome
    Christopoulos, Georgios
    Vlismas, Antonios
    Carby, Anna
    Lavery, Stuart
    Trew, Geoffrey
    [J]. HUMAN FERTILITY, 2016, 19 (03) : 199 - 206
  • [50] Administration of gonadotropin-releasing hormone agonist during the luteal phase of GnRH-antagonist IVF cycles
    Hugues, J. N.
    Cedrin-Durnerin, I.
    Bstandig, B.
    Theron-Gerard, L.
    Grange, D.
    Laffy, A.
    Clement, P.
    Hamidi, J.
    Sifer, C.
    Poncelet, C.
    [J]. HUMAN REPRODUCTION, 2006, 21 : I3 - I3
12345